Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AryoGen recombinant factor VIIa versus NovoSeven in congenital hemophilia A/B with inhibitors
IRCT201202106302N2Phase 3Completed
- Sponsor
- AryoGen Biopharma
- Start
- Feb 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of coagulation factor VIIa in hemophilia A and hemophilia B (HB) (2 arms), sponsored by AryoGen Biopharma. Started Feb 2012; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on IRCT201202106302N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201202106302N2.